Cargando…

Targeting CD19 in B-cell lymphoma: emerging role of SAR3419

Non-Hodgkin lymphoma symbolizes a heterogeneous group of diseases resulting from malignant transformation of lymphocytes with differing patterns of behavior and responses to treatment. The potential curability of non-Hodgkin lymphoma differs among the various histologic subtypes and is associated in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raufi, Ali, Ebrahim, Abdul Shukkur, Al-Katib, Ayad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3767487/ https://www.ncbi.nlm.nih.gov/pubmed/24023523 http://dx.doi.org/10.2147/CMAR.S45957

Ejemplares similares

Isolation and characterization of a CD34(+) sub-clone in B-cell lymphoma
por: Al-Katib, Ayad M., et al.
Publicado: (2020)

Modulation of deoxycytidine kinase (dCK) and glycogen synthase kinase (GSK-3β) by anti-CD20 (rituximab) and 2-chlorodeoxyadenosine (2-CdA) in human lymphoid malignancies
por: Al-Katib, Ayad M, et al.
Publicado: (2014)

PNT2258, a novel deoxyribonucleic acid inhibitor, induces cell cycle arrest and apoptosis via a distinct mechanism of action: a new class of drug for non-Hodgkin's lymphoma
por: Ebrahim, Abdul Shukkur, et al.
Publicado: (2016)

Unintended target effect of anti-BCL-2 DNAi
por: Ebrahim, Abdul Shukkur, et al.
Publicado: (2017)

The novel CD19-targeting antibody-drug conjugate huB4-DGN462 shows improved anti-tumor activity compared to SAR3419 in CD19-positive lymphoma and leukemia models
por: Hicks, Stuart W., et al.
Publicado: (2019)

New targets for the treatment of follicular lymphoma
por: Tageja, Nishant, et al.
Publicado: (2009)

A phase II multicenter study of the anti-CD19 antibody drug conjugate coltuximab ravtansine (SAR3419) in patients with relapsed or refractory diffuse large B-cell lymphoma previously treated with rituximab-based immunotherapy
por: Trnĕný, Marek, et al.
Publicado: (2018)

Spatio-temporal regulation of EGFR signaling by the Eps15 homology domain-containing protein 3 (EHD3)
por: Amessou, Mohamed, et al.
Publicado: (2016)

Composite Lymphoma: Opposite Ends of Spectrum Meet
por: Khan, Uqba, et al.
Publicado: (2017)

Emergence of overt myeloma in a patient with chronic lymphocytic leukemia on ibrutinib therapy
por: Al‐Katib, Ayad M., et al.
Publicado: (2020)

Patients' and families' opinions via suggestion boxes for improving hospital care for cancer patients: Analysis of 3419 cases over 11 years
por: Takao, Kenji, et al.
Publicado: (2021)

Correction: Dueñas et al. Assessing Effectiveness of Colonic and Gynecological Risk Reducing Surgery in Lynch Syndrome Individuals. Cancers 2020, 12, 3419
por: Dueñas, Nuria, et al.
Publicado: (2021)

Primary Cardiac Lymphoma: Lessons Learned from a Long Survivor
por: Singh, Baljit, et al.
Publicado: (2016)

HDM2 antagonist MI-219 (spiro-oxindole), but not Nutlin-3 (cis-imidazoline), regulates p53 through enhanced HDM2 autoubiquitination and degradation in human malignant B-cell lymphomas
por: Sosin, Angela M, et al.
Publicado: (2012)

The Value of EphB2 Receptor and Cognate Ephrin Ligands in Prognostic and Predictive Assessments of Human Breast Cancer
por: Ebrahim, Abdul Shukkur, et al.
Publicado: (2021)

Intravascular Large B-Cell Lymphoma Presenting with Diffuse Gallbladder Wall Thickening: A Case Report and Literature Review
por: Al-Katib, Sayf, et al.
Publicado: (2018)

Coagulation and anticoagulation in COVID-19
por: Hadid, Tarik, et al.
Publicado: (2021)

Lymphomatoid Granulomatosis in a Patient with Chronic Lymphocytic Leukemia and Rapidly Progressing Peribronchovascular Pulmonary Infiltrates
por: Rezvani, Shahab, et al.
Publicado: (2019)

CD81 as target for B cell lymphomas
por: Küppers, Ralf
Publicado: (2019)

I-kappa-kinase-2 (IKK-2) inhibition potentiates vincristine cytotoxicity in non-Hodgkin's lymphoma
por: Al-Katib, Ayad, et al.
Publicado: (2010)

Preclinical studies of Apogossypolone: a new nonpeptidic pan small-molecule inhibitor of Bcl-2, Bcl-X(L )and Mcl-1 proteins in Follicular Small Cleaved Cell Lymphoma model
por: Arnold, Alan A, et al.
Publicado: (2008)

Syncytial giant cell hepatitis associated with chronic lymphocytic leukemia: a case report
por: Gupta, Eva, et al.
Publicado: (2012)

An MDM2 antagonist (MI-319) restores p53 functions and increases the life span of orally treated follicular lymphoma bearing animals
por: Mohammad, Ramzi M, et al.
Publicado: (2009)

ER stress response plays an important role in aggregation of α-synuclein
por: Jiang, Peizhou, et al.
Publicado: (2010)

Atrioventricular Nodal Re-entrant Tachycardia Ablation: Unusual Function of Slow Pathway
por: Al-Sayegh, Ali, et al.
Publicado: (2011)

Development and antitumor activity of a BCL-2 targeted single-stranded DNA oligonucleotide
por: Rodrigueza, Wendi V., et al.
Publicado: (2014)

Functional optimization of electric cell-substrate impedance sensing (ECIS) using human corneal epithelial cells
por: Ebrahim, Abdul Shukkur, et al.
Publicado: (2022)

Thrombotic thrombocytopenic purpura presenting as acute coronary syndrome
por: Mouabbi, Jason Aboudi, et al.
Publicado: (2016)

CD81 is a novel immunotherapeutic target for B cell lymphoma
por: Vences-Catalán, Felipe, et al.
Publicado: (2019)

CD19-Targeted Immunotherapies for Diffuse Large B-Cell Lymphoma
por: Gambella, Massimiliano, et al.
Publicado: (2022)

SMI of Bcl-2 TW-37 is active across a spectrum of B-cell tumors irrespective of their proliferative and differentiation status
por: Al-Katib, Ayad M, et al.
Publicado: (2009)

Chimeric antigen receptor T cells to target CD79b in B-cell lymphomas
por: Chu, Fuliang, et al.
Publicado: (2023)

Adjunctive Thymosin Beta-4 Treatment Influences MΦ Effector Cell Function to Improve Disease Outcome in Pseudomonas aeruginosa-Induced Keratitis
por: Wang, Yuxin, et al.
Publicado: (2021)

Adjunctive Thymosin Beta-4 Treatment Influences PMN Effector Cell Function during Pseudomonas aeruginosa-Induced Corneal Infection
por: Wang, Yuxin, et al.
Publicado: (2021)

United we stand: Double targeting of CD79B and CD20 in diffuse large B‐cell lymphoma
por: Tarantelli, Chiara, et al.
Publicado: (2022)

Type II Collagen Induces Peripheral Tolerance in BALB/c Mice via the Generation of CD8(+) T Regulatory Cells
por: Farooq, Shukkur M., et al.
Publicado: (2012)

Development of a Bispecific Nanobody Targeting CD20 on B-Cell Lymphoma Cells and CD3 on T Cells
por: Liu, Yanlong, et al.
Publicado: (2022)

Antimicrobial Effects of Thymosin Beta-4 and Ciprofloxacin Adjunctive Therapy in Pseudomonas aeruginosa Induced Keratitis
por: Carion, Thomas W., et al.
Publicado: (2020)

Antibody-targeted paclitaxel loaded nanoparticles for the treatment of CD20(+) B-cell lymphoma
por: Nevala, Wendy K., et al.
Publicado: (2017)

Targeting CD19 in diffuse large B‐cell lymphoma: An expert opinion paper
por: Bailly, Sarah, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cj8h4kn10gq8it4fb9mkm950fk